Parallax Volatility Advisers
NVO

Parallax Volatility Advisers’s Novo Nordisk NVO Stock Holding History

Parallax Volatility Advisers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.4M Buy
315,600
+22,900
+8% +$1.09M 0.03% 354
2025
Q4 		$14.9M Sell
292,700
-134,900
-32% -$6.9M 0.03% 364
2025
Q3 		$23.7M Buy
427,600
+172,500
+68% +$10.1M 0.04% 262
2025
Q2 		$17.6M Sell
255,100
-8,200
-3% -$558K 0.04% 299
2025
Q1 		$18.3M Buy
263,300
+35,000
+15% +$2.89M 0.05% 293
2024
Q4 		$19.6M Buy
228,300
+18,700
+9% +$2.02M 0.04% 345
2024
Q3 		$25M Buy
209,600
+88,000
+72% +$11.7M 0.05% 280
2024
Q2 		$17.4M Buy
121,600
+82,500
+211% +$10.9M 0.04% 326
2024
Q1 		$5.02M Buy
+39,100
New +$4.65M 0.01% 732
2023
Q3 		– Sell
-141,000
Closed -$11.4M – 2508
2023
Q2 		$11.4M Buy
+141,000
New +$11.5M 0.02% 496

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Parallax Volatility Advisers's NVO Position: Q1 2026 in Review

Parallax Volatility Advisers reduced its Novo Nordisk (NVO) stake by 74% in Q1 2026, selling an estimated $1.59M and leaving 11,936 shares worth $471K. The position accounts for ﹤0.01% of the portfolio, ranked #1071.

Parallax Volatility Advisers first reported a position in NVO in Q1 2018 and has held it in 17 quarters since. The position peaked at $12.1M in Q3 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Parallax Volatility Advisers held 11,936 shares of Novo Nordisk worth $471K as of Q1 2026.
  • Parallax Volatility Advisers sold 33,490 Novo Nordisk shares in Q1 2026, an estimated $1.59M.
  • Novo Nordisk made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #1071 holding.
  • Parallax Volatility Advisers first reported a position in Novo Nordisk in Q1 2018 and has held it in 17 quarters since.
  • Parallax Volatility Advisers's Novo Nordisk position peaked at $12.1M in Q3 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.